Back to results
US 2021/0311031 A1Published application
Methods and compositions for removing biotin interference from assays using molecular traps
AssigneeSiemens Healthcare Diagnostics Inc.
InventorsTie Wei, Zhu Teng, Izak Bahar
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions to remove or reduce biotin interference from certain assays.
Claims10
A molecular trap to reduce free-hapten interference in an assay, the molecular trap comprising:
- a molecular structure soluble in an assay solution to selectively bind free-hapten, the molecular structure comprising a modified specific binding partner (sbp) to the free-hapten, the modified sbp comprising one or more of a dextran aldehyde component, a bound steric-hindering polymer, and slower specific free-hapten binding off-rate characteristics than other free-hapten specific binding partners (sbps) assay reagents.
Dependencies are inferred from the claim text.